Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Enliven Therapeutics (ELVN) Q4 2022 Earnings
ELVN
10
Feb
Expected
Q1 2022
Q2 2022
Q3 2022
Q4 2022
-2.24
-1.09
0.06
1.21
Details
Expected EPS
-0.786
Actual EPS
1.21
Surprise EPS
2
Surprise Percent
+253.94%
Description
Enliven Therapeutics (ELVN) has reported earnings of 1.21 per share for Q4 2022.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login